1 not yet recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Not yet recruiting 1 |
Follow TQB2825 Injection (Subcutaneous Injection): new trials by email Literature Review of TQB2825 Injection (Subcutaneous Injection) trials Research Report on TQB2825 Injection (Subcutaneous Injection)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I Clinical Trial of TQB2825 Subcutaneous Injection in CD20-positive Hematological Malignancies TQB2825 Injection (Subcutaneous Injection) - CD20-positive Hematological Malignancies | Phase 1 | Not yet recruiting | Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. | 75 | 2025-09-01 | 2025-08-07 |
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. (1)
China (1)